Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants

Neurobiology of Disease

Volumn 35, Issue 3, 2009, Pages 477-488

  Gaillard, Afsaneh ^a   Decressac, Mickael ^a   Frappé, Isabelle ^a   Fernagut, Pierre Olivier ^b   Prestoz, Laetitia ^a   Besnard, Stephan ^a   Jaber, Mohamed ^a  

^a UNIVERSITÉ DE POITIERS   (France)

^b UMR 5287   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; DOPAMINE; DOPAMINE TRANSPORTER; G PROTEIN COUPLED RECEPTOR KINASE 2; GREEN FLUORESCENT PROTEIN; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; FEMALE; FOREBRAIN; GRAFT RECIPIENT; MESENCEPHALON; MOTOR CORTEX; MOUSE; MOUSE EMBRYO; NERVE FIBER GROWTH; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TEGMENTUM; TRANSGENIC MOUSE; WILD TYPE;

AGING; ANIMALS; BRAIN TISSUE TRANSPLANTATION; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FETAL TISSUE TRANSPLANTATION; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GREEN FLUORESCENT PROTEINS; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURAL PATHWAYS; NEURONS; OLFACTORY BULB; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 68249137197     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.003     Document Type: Article

References (48)

1. Barc S., et al. Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat. J. Neurochem. 80 (2002) 365-374
2. Bjorklund A. Dopaminergic transplants in experimental parkinsonism: cellular mechanisms of graft-induced functional recovery. Curr. Opin. Neurobiol. 2 (1992) 683-689
3. Bjorklund A., et al. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199 (1980) 307-333
4. Bjorklund A., et al. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 522 (1983) 1-7
5. Bjorklund L.M., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2344-2349
6. Bolam J.P., et al. Synaptic input and local output of dopaminergic neurons in grafts that functionally reinnervate the host neostriatum. Exp. Brain Res. 68 (1987) 131-146
7. Cheramy A., et al. Dendritic release of dopamine in the substantia nigra. Nature 289 (1981) 537-542
8. Damier P., et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122 Pt 8 (1999) 1421-1436
9. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
10. Doucet G., et al. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp. Neurol. 106 (1989) 1-19
11. Freeman T.B., et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38 (1995) 379-388
12. Gaillard A., and Jaber M. Is the outgrowth of transplant-derived axons is guided by host astrocytes and myelin loss?. Cell Adhes. Migr. 1 (2007) 161-164
13. Gaillard A., and Jaber M. Repair of damaged adult cortex by transplantation of embryonic neurons. Med. Sci. (Paris) 24 (2008) 132-134
14. Gaillard A., et al. Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nat. Neurosci. 10 (2007) 1294-1299
15. Gaspard N., et al. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 455 (2008) 351-357
16. Gauchy C., et al. The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat. Neuroscience 22 (1987) 935-946
17. Inanobe A., et al. Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci. 19 (1999) 1006-1017
18. Inzelberg R., et al. Onset age of Parkinson disease. Am. J. Med. Genet. 111 (2002) 459-460 author reply 461
19. Jaber M., et al. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11 (1999) 3499-3511
20. Kordower J.H., et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14 (2008) 504-506
21. Li J.Y., et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14 (2008) 501-503
22. Liang C.L., et al. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin. Neuroscience 75 (1996) 523-533
23. Lindvall O., and Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 1 (2004) 382-393
24. Lindvall O., et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46 (1989) 615-631
25. Mahalik T.J., and Clayton G.H. Specific outgrowth from neurons of ventral mesencephalic grafts to the catecholamine-depleted striatum of adult hosts. Exp. Neurol. 113 (1991) 18-27
26. McRitchie D.A., et al. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. Comp. Neurol. 364 (1996) 121-150
27. Mendez I., et al. Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note. J. Neurosurg. 92 (2000) 493-499
28. Mendez I., et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J. Neurosurg. 96 (2002) 589-596
29. Mendez I., et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128 (2005) 1498-1510
30. Mendez I., et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14 (2008) 507-509
31. Mukhida K., et al. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. J. Neurosci. 21 (2001) 3521-3530
32. Nakao N., et al. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J. Neurosci. 18 (1998) 1806-1817
33. Nikkhah G., et al. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci. 14 (1994) 3449-3461
34. Okabe M., et al. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407 (1997) 313-319
35. Olanow C.W., et al. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19 (1996) 102-109
36. Olsson M., et al. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15 (1995) 3863-3875
37. Paul G. Cell transplantation for patients with Parkinson's disease. Handb. Exp. Pharmacol. (2006) 361-388
38. Peschanski M., et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117 Pt. 3 (1994) 487-499
39. Robertson H.A. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci. 15 (1992) 201-206
40. Rogers J.H. Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase. Brain Res. 587 (1992) 203-210
41. Schein J.C., et al. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev. Biol. 204 (1998) 432-450
42. Thompson L., et al. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 25 (2005) 6467-6477
43. Thompson L.H., et al. Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain. Exp. Neurol. 213 (2008) 220-228
44. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 485-493
45. West M.J. Design-based stereological methods for counting neurons. Prog. Brain Res. 135 (2002) 43-51
46. West M.J., et al. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231 (1991) 482-497
47. Winkler C., et al. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp. Neurol. 155 (1999) 165-186
48. Yurek D.M. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp. Neurol. 143 (1997) 1-9